BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36220879)

  • 1. Galectin-3 binding protein stimulated IL-6 expression is impeded by antibody intervention in SARS-CoV-2 susceptible cell lines.
    Mendes-Frias A; Gallo V; Iacobelli V; Gentile R; Antonini G; Silvestre R; Iacobelli S
    Sci Rep; 2022 Oct; 12(1):17047. PubMed ID: 36220879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gal-3BP in Viral Infections: An Emerging Role in Severe Acute Respiratory Syndrome Coronavirus 2.
    Gallo V; Arienzo A; Iacobelli S; Iacobelli V; Antonini G
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection.
    Bozorgmehr N; Mashhouri S; Perez Rosero E; Xu L; Shahbaz S; Sligl W; Osman M; Kutsogiannis DJ; MacIntyre E; O'Neil CR; Elahi S
    mBio; 2021 May; 12(3):. PubMed ID: 33947753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A galectin-3-dependent pathway upregulates interleukin-6 in the microenvironment of human neuroblastoma.
    Silverman AM; Nakata R; Shimada H; Sposto R; DeClerck YA
    Cancer Res; 2012 May; 72(9):2228-38. PubMed ID: 22389450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Galectin-9 Potently Enhances SARS-CoV-2 Replication and Inflammation in Airway Epithelial Cells.
    Du L; Bouzidi MS; Gala A; Deiter F; Billaud JN; Yeung ST; Dabral P; Jin J; Simmons G; Dossani Z; Niki T; Ndhlovu LC; Greenland JR; Pillai SK
    bioRxiv; 2022 May; ():. PubMed ID: 35378763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19.
    Al-Kuraishy HM; Al-Gareeb AI; Mostafa-Hedeab G; Kasozi KI; Zirintunda G; Aslam A; Allahyani M; Welburn SC; Batiha GE
    Front Immunol; 2021; 12():749291. PubMed ID: 34867978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-3 Binding Protein and Galectin-1 Interaction in Breast Cancer Cell Aggregation and Metastasis.
    Lin TW; Chang HT; Chen CH; Chen CH; Lin SW; Hsu TL; Wong CH
    J Am Chem Soc; 2015 Aug; 137(30):9685-93. PubMed ID: 26168351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Gal-3BP plasma levels in hospitalized patients infected with SARS-CoV-2.
    Gallo V; ; Gentile R; Antonini G; Iacobelli S
    Clin Exp Med; 2023 Feb; 23(1):151-155. PubMed ID: 35076790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory deficiencies in neutrophilic asthma: reduced galectin-3 and IL-1RA/IL-1β.
    Gao P; Gibson PG; Baines KJ; Yang IA; Upham JW; Reynolds PN; Hodge S; James AL; Jenkins C; Peters MJ; Zhang J; Simpson JL
    Respir Res; 2015 Jan; 16(1):5. PubMed ID: 25616863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronavirus Disease-2019 Treatment Strategies Targeting Interleukin-6 Signaling and Herbal Medicine.
    Dzobo K; Chiririwa H; Dandara C; Dzobo W
    OMICS; 2021 Jan; 25(1):13-22. PubMed ID: 32857671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute hantavirus infection induces galectin-3-binding protein.
    Hepojoki J; Strandin T; Hetzel U; Sironen T; Klingström J; Sane J; Mäkelä S; Mustonen J; Meri S; Lundkvist Å; Vapalahti O; Lankinen H; Vaheri A
    J Gen Virol; 2014 Nov; 95(Pt 11):2356-2364. PubMed ID: 25013204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone.
    Olajide OA; Iwuanyanwu VU; Lepiarz-Raba I; Al-Hindawi AA
    Inflammation; 2021 Oct; 44(5):1865-1877. PubMed ID: 33860869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody therapy in COVID-19.
    Conti P; Pregliasco FE; Calvisi V; Caraffa Al; Gallenga CE; Kritas SK; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(2):423-427. PubMed ID: 33904269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages.
    Pantazi I; Al-Qahtani AA; Alhamlan FS; Alothaid H; Matou-Nasri S; Sourvinos G; Vergadi E; Tsatsanis C
    Front Immunol; 2021; 12():683800. PubMed ID: 34248968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Hybrid Soluble gp130/Spike-Nanobody Fusion Protein Simultaneously Blocks Interleukin-6
    Ettich J; Werner J; Weitz HT; Mueller E; Schwarzer R; Lang PA; Scheller J; Moll JM
    J Virol; 2022 Feb; 96(4):e0162221. PubMed ID: 34935434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-nucleocapsid antibodies enhance the production of IL-6 induced by SARS-CoV-2 N protein.
    Nakayama EE; Kubota-Koketsu R; Sasaki T; Suzuki K; Uno K; Shimizu J; Okamoto T; Matsumoto H; Matsuura H; Hashimoto S; Tanaka T; Harada H; Tomita M; Kaneko M; Yoshizaki K; Shioda T
    Sci Rep; 2022 May; 12(1):8108. PubMed ID: 35577892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum galectin 3, galectin 9 and galectin 3-binding proteins in patients with active and inactive inflammatory bowel disease.
    Cibor D; Szczeklik K; Brzozowski B; Mach T; Owczarek D
    J Physiol Pharmacol; 2019 Feb; 70(1):. PubMed ID: 31019124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gal-3BP Negatively Regulates NF-κB Signaling by Inhibiting the Activation of TAK1.
    Hong CS; Park MR; Sun EG; Choi W; Hwang JE; Bae WK; Rhee JH; Cho SH; Chung IJ
    Front Immunol; 2019; 10():1760. PubMed ID: 31402917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.